SP
Starget Pharma Inc.
SEC filingBiotechnology · Shreveport, LA
Amount raised$16.4Msold at filing
Total offering$22.2M$5.8M still open
Investors in the raise29count reported to the SEC
FiledFeb 3, 2026first sale Jan 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ronen KalmansonDirector
Sigal Kalmanson CusnirExecutive Officer
Executive officers, directors and promoters as listed on the Form D.